Innovative Pediatric Formulations: Ibuprofen in Chocolate-Coated Honey Core
- 32 Downloads
The pediatric population is represented by a diverse group of patients and, as a consequence, additional factors and parameters determining their dosage and taste must be taken into account. The aim of this work is to prepare and analyze an innovative chewable solid drug formulation that would appeal to pediatric patients. In particular, the present study presents a new taste masking processing wherein the drug’s disagreeable taste and the associated unpleasant throat burning sensation are covered with honey and chocolate.
Ibuprofen was used as the active pharmaceutical ingredient dispersed in formula after being suitably pretreated. Honey and agar are the two main excipients of the formulation while the new pharmaceutical preparation is further coated with milk chocolate to mask its bitter taste. Vitamins A and E were also added in a separate formula as an alternative choice which, apart from the curative action of ibuprofen, display additional benefits. During the development of the analytical methods, liquid/solid and solid phase extraction was performed. Moreover, for the chromatographic determination, a RP-C18 column and two different mobile phases containing acetonitrile and phosphate buffer were used.
The methods were validated on the basis of international guidelines. The recoveries of the active ingredients were 97–102% while the RSD values were 0.06–0.53%. The new preparation was found to be stable for at least 1 year.
Considering children’s difficulty in swallowing medicines with a bitter taste, palatable ibuprofen formulations were made. Their preparative and analytic methods were validated according to ICH guidelines.
KeywordsPediatric medicines Honey Milk chocolate Vitamin A Vitamin E Ibuprofen
- 2.RegulationECNo.1901/2006, http://eurlex.europa.eu/LexUriServ/LexUriServ.do/ uri=OJ:L:2006:378:0001:0019, 2013.
- 5.Abraham J, Flowerlet M. Taste masking of peadiatric formulation: a review on technologies, recent trends and regulatory aspects. Int J Pharm Pharm Sci. 2014;6:1.Google Scholar
- 6.Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R, et al. On behalf of the European Formulation Initiative (EuPFI): playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014;73:14–33.Google Scholar
- 7.Reiland Thomas L, Lipari John M. Encyclopedia of pharmaceutical technology. 3rd ed: Flavours and flavor modifiers. p. 1763–72.Google Scholar
- 8.Sharma S, Lewis S. Taste masking technologies: a review. Int J Pharm Pharm Sci. 2010;2(2):6–13.Google Scholar
- 9.Lieberman HA, Lachman L. Chewable tablets. In: Pharmaceutical dosage forms, vol. 1. New York: Marcel Dekker Inc; 1981. p. 387–91.Google Scholar
- 10.Roy G. Modifying bitterness, Technomic Publishing Co, London England; 1997. p. 179-211.Google Scholar
- 11.tripithi A, parmar D, patel U, patel G. Taste masking: novel approach for bitter and obnoxious drugs. JPSBR. 2011;1(3):136–42.Google Scholar
- 12.Deasy. Ion exchange resin in microencapsulation. Newyork: Marcel Dekker Inc; 1980. p. 150.Google Scholar
- 13.Wehling F., Schuehle S. Effervescent dosage forms with microparticles. US Patent 5,178,878, 1993.Google Scholar
- 15.Depalmo GA. Composition based on ibuprofen, for oral usage. Eur Pat Appl. 1993;EP0560207.Google Scholar
- 17.Ueki T., Kameda S., Uno D., Kaneko K. Dentifrices composition. JP 05,155,744, June 22, 1993.Google Scholar
- 18.Fuisz R. C. Taste masking of pharmaceutical floss with phenol. US Patent 5,028,632, July 2, 1991.Google Scholar
- 29.Popescu M. C., Mertz E. T. Taste moderating pharmaceutical. US Patent 5,009,819, April 23, 1991.Google Scholar
- 30.Kurtz R. J., Fuller W. D. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers. US Patent 5,232,735, 1993.Google Scholar
- 35.https://en.wikipedia.org/wiki/IbuprofenGoogle Scholar
- 37.Rainsford KD. Ibupropfen, a critical bibliographic review: Tailor and Francis; 2005.Google Scholar
- 38.Walter K, Weiss G, Laichern A, Stanislaus F. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules, pubmed.gov, 1995.Google Scholar
- 39.Urvi G, Harsh C. Taste masking in pharmaceutical industry. Am Pharm Rev. 2014.Google Scholar
- 41.Hu Y, Pan J, Liao W, Li J, Gruget P, Kitts D, et al. Determination of antioxidant capacity and phenolic content of chocolate by attenuated total reflectance-Fourier transformed-infrared spectroscopy. Food Chem. 2016;202:254–61.Google Scholar
- 42.ICH. Harmonized tripartite guideline: validation of analytical procedures: text and methodology Q2(R1). 4th ed: EMEA; 2006.Google Scholar
- 43.US Pharmacopoeia (USP 29), Ibuprofen tablets.Google Scholar